Abstract
A series of 2-((4-fluorophenyl)thio)quinoline linked (bis)-trifluoromethyl substituted N-arylquinolone derivatives 8a–x have been synthesized via a one-pot multicomponent reaction. The newly synthesized compounds were characterized by FT-IR, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. In vitro antimicrobial activity of the synthesized compounds was investigated against a representative panel of pathogenic strains by Broth microdilution method and in vitro antituberculosis activity was evaluated against Mycobacterium tuberculosis H37Rv bacteria by Lowenstein–Jensen method.
Similar content being viewed by others
References
Alfredson TV, Maki AH, Waring M (1991) Optically detected triplet-state magnetic resonance studies of the DNA complexes of the bisquinoline analogue of echinomycin. Biochemistry 30:9665–9675
Amit N, Vikramdeep M, Alpeshkumar M, Rahul E (2007) Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines. Bioorg Med Chem 15:626–640
Annamaria L, Jialin M, Baojie W, Yuehong W, Scott GF, Alan PK (2009) Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. J Med Chem 52:2109–2118
Bloch AB, Cauthen GM, Onorato IM, Kenneth G, Dandbury G, Kelly GD, Driver CR, Snider DE (1994) Nationwide survey of drug-resistant tuberculosis in the United States. J Am Med Assoc 271:665–671
Centers for Disease Control Prevention (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000 2004. MMWR Recomm Rep 55:301–305
Chai Y, Wan ZL, Wang B, Guo HY, Liu ML (2009) Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives. Eur J Med Chem 44:4063–4069
Guillon J, Moreau S, Mouray E, Sinou V, Forfar I, Fabre SB, Desplat V, Millet P, Parzy D, Jarry C, Grellier P (2008) New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity. Bioorg Med Chem 16:9133–9144
Hagmann WK (2008) The many roles for fluorine in medicinal chemistry. J Med Chem 51:4359–4369
Jardosh HH, Patel MP (2013) Design and synthesis of biquinolone–isoniazid hybrids as a new class of antitubercular and antimicrobial agents. Eur J Med Chem 65:348–359
Kanani MB, Patel MP (2013) Synthesis and in vitro antimicrobial evaluation of novel 2-amino-6-(phenylthio)-4-(2-(phenylthio)quinolin-3-yl)pyridine-3,5-dicarbonitriles. Med Chem Res 22:2912–2920
Kathrotiya HG, Patel MP (2013) Synthesis and identification of β-aryloxyquinoline based diversely fluorine substituted N-aryl quinolone derivatives as a new class of antimicrobial, antituberculosis and antioxidant agents. Eur J Med Chem 63:675–684
Kaur K, Jain M, Khan SI, Jacob MR, Tekwani BR, Singh S, Singh PP, Jaina R (2011) Synthesis, antiprotozoal, antimicrobial, β-hematin inhibition, cytotoxicity and methemoglobin (MetHb) formation activities of bis(8-aminoquinolines). Bioorg Med Chem 19:197–201
Larghi EL, Bohn ML, Kaufman TS (2009) Aaptamine and related products. Their isolation, chemical syntheses, and biological activity. Tetrahedron 65:4257–4282
Meth-Cohn O, Bramha NA (1978) A versatile new synthesis of quinolines, thionopyridine and related fused pyridines. Tetrahedron Lett 23:2045–2048
Mital A, Negi AS, Ramachandran U (2006) Synthesis and antimycobacterial activities of certain trifluoromethyl-aminoquinoline derivatives. ARKIVOC 10:220–227
Muller K, Faeh C, Diederich F (2007) Fluorine in pharmaceuticals: looking beyond intuition. Science 317:1881–1886
NCCLS (National Committee for Clinical Laboratory Standards) 2002 Performance standards for antimicrobial susceptibility testing: Twelfth informational supplement. ISBN 1-56238-454-6, M100-S12 (M7).
Palit P, Paira P, Hazra A, Banerjee S, Gupta AD, Dastidar SG, Mondal NB (2009) Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial. Eur J Med Chem 44:845–853
Purser S, Moore PR, Swallow S, Gouverneur V (2008) Fluorine in medicinal chemistry. Chem Soc Rev 37:320–330
Rastogi N, Kochi A, Vareldzis B, Styblo K, Crawford JT, Jarvis WR, McGowan JE, Perrone CJ, David HL, Zhang Y, Cohn DL, Iseman MD (1993a) Emergence of multiple-drug-resistance tuberculosis: fundamental and applied research aspects, global issues and current strategies. Res Microbiol 144:103–158
Rastogi N, Ross BC, Dwyer B, Goh KS, Clavel-Seres S, Jeantils V, Cruaud P (1993b) Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 11:901–907
Rattan A (2000) Antimicrobials in laboratory medicine. B.I. Churchill Livingstone, New Delhi, pp 85–108
Raviglione MC, Smith I (2007) XDR tuberculosis—implications for global public health. N Engl J Med 356:656–659
Raynes K, Galatis D, Cowman AF, Tilley L, Deady LW (1995) Synthesis and activity of some antimalarial bisquinolines. J Med Chem 38:204–206
Shah NM, Patel MP, Patel RG (2012) New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation. Eur J Med Chem 54:239–247
Strekowski L, Say M, Zegrocka O, Tanious FA, Wilson WD, Manzel L, Macfarlane DE (2003) Bis-4-aminoquinolines: novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides. Bioorg Med Chem 11:1079–1085
Tewari S, Chauhan PMS, Bhaduri AP, Fatima N, Chatterjee RK (2000) Syntheses and antifilarial profile of 7-chloro-4-(substituted amino) quinolines: a new class of antifilarial agents. Bioorg Med Chem Lett 10:1409–1412
Vennerstrom JL, Ellis WY, Ager AL, Anderaen SL, Gerena L, Milhous WK (1992) Bisquinolines. 1. N, N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria. J Med Chem 35:2129–2134
Villemagne B, Crauste C, Flipo M, Baulard MR, Déprez B, Willand N (2012) Tuberculosis: the drug development pipeline at a glance. Eur J Med Chem 51:1–16
World Health Organization, Global tuberculosis report 2012, ISBN 978 92 4 1564502
Acknowledgments
The authors are thankful to the Head, Department of Chemistry, Sardar Patel University for providing 1H NMR, 13C NMR spectroscopy and research facilities. We are also thankful to DST, New Delhi for the assistance in general and for the PURSE central facility for mass spectrometry sponsored under PURSE program Grant vide sanction letter DO. No. SR/59/Z-23/2010/43,Vaibhav Laboratories, Ahmedabad, Gujarat, India for the FT-IR, SICART, Vallabh Vidyanagar, for elemental analysis and Dhanji P. Rajani, Microcare Laboratory, Surat, Gujarat, India for antimicrobial and antituberculosis screening of the compounds reported herein. One of the authors is grateful to UGC, New Delhi for Research Fellowship in Sciences for Meritorious Students.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kanani, M.B., Patel, M.P. Design and synthesis of new (bis)trifluoromethyl-promoted N-aryl biquinoline derivatives as antitubercular and antimicrobial agents. Med Chem Res 24, 563–575 (2015). https://doi.org/10.1007/s00044-014-1140-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-014-1140-8